Evidence map›Paper›PMID 31480522›Full record

ArticleCancers2019

K

Corinna J Mohr, Dominic Gross, Efe C Sezgin, Friederike A Steudel, Peter Ruth, Stephan M Huber, Robert Lukowski

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Imaging of KChemMedChem · 2023
    Article
  8. Review
  9. Article
  10. IKCell death & disease · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Investigating the KSTAR protocols · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Co-staining of KChemMedChem · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Corinna J MohrDepartment of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tuebingen, 72076 Tuebingen, Germany.
Dominic GrossDepartment of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tuebingen, 72076 Tuebingen, Germany.
Efe C SezginDepartment of Radiation Oncology, University of Tuebingen, 72076 Tuebingen, Germany.
Friederike A SteudelDepartment of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tuebingen, 72076 Tuebingen, Germany.
Peter RuthDepartment of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tuebingen, 72076 Tuebingen, Germany.
Stephan M HuberDepartment of Radiation Oncology, University of Tuebingen, 72076 Tuebingen, Germany. stephan.huber@uni-tuebingen.de.
Robert LukowskiDepartment of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tuebingen, 72076 Tuebingen, Germany. robert.lukowski@uni-tuebingen.de.
University of Tübingen · DEDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology · DE

Funding

Deutsche Forschungsgemeinschaft none
6 · The paper itself

Abstract

K

Indexed as

breast cancerIKintermediate conductance calcium-activated potassium channelionizing radiationKCa3.1KCNN4MMTV-PyMTmouse mammary tumor virus polyoma middle T antigenSK4TRAM-34

Identifiers

PMID31480522
PMCPMC6770875
OpenAlexW2970864773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.